However, Uzgare et al reported that although there was a slight increase in ERK and p38 in well-differentiated cancers, cells from hormone refractory prostate cancer had reduced or absent activated expression of isoforms.[68] Furthermore, Malik et al found a decrease in activated form phospho-MAPK/ERK in high-grade tumors.[69]. The gene discussed is MAPK1; the disease is cancer.